Australian ophthalmologists have published the first independent head-to-head comparison of two leading minimally invasive glaucoma surgery (MIGS) devices, finding no significant difference in intraocular pressure (IOP) outcomes but a potential greater reduction in medication use in one group.
Designs For Vision is now supplying the iCare HOME2 tonometer, which it says revolutionises glaucoma care by enabling patients to capture their own intraocular pressure (IOP) at different times of the day and night. Read More
Medicinal cannabis is often presented as an alternative treatment for glaucoma. Although there is evidence that cannabis lowers intraocular pressure, its role as a viable glaucoma therapy is limited by a short duration of action, psychotropic effects, and possible tachyphylaxis. Read More
In a finding that may have significant implications for how glaucoma is diagnosed and managed, researchers from the University of South Florida (USF) have found that both eye and brain pressure are physiologically connected.